参考文献/References:
[1]陈洲芳.拉贝洛尔联合硫酸镁治疗早发型重度子痫前期疗效观察 [J].中国基层医药,2011,18 (16):2231-2232.
[2]姚兰,黎丽,王晓怡.拉贝洛尔与硝酸甘油治疗重度子痫前期的疗效对比研究 [J].中国医师杂志,2011,13 (7):986-988.
[3]王占山.拉贝洛尔联用硫酸镁治疗早发型重度子痫前期132例临床分析 [J].中国煤炭工业医学杂志,2011,14 (4):543-544.
[4]张鸿.硫酸镁联合可拉贝洛尔治疗早发型重度子痫前期的临床观察 [J].中国初级卫生保健,2011,25 (4):108-109.
[5]Naruse K, Sado T, Noguchi T, et al. Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response [J]. J Reprod Immunol, 2012, 93 (2): 69-74.
[6]蔡冰.硫酸镁联合拉贝洛尔治疗子痫前期66例临床分析 [J].山东医药,2008,48 (4):96.
[7]Kodama M, Miyoshi H, Fujito N, et al. Plasma mRNA concentrations of placenta-specific 1 (PLAC1) and pregnancy associated plasma protein A (PAPP-A) are higher in early-onset than lateonset preeclampsia[J]. J Obstet Gynaecol Res, 2011, 37(4): 313-318.
[8]张薇.硫酸镁对子痫前期患者子宫动脉、螺旋动脉及胎儿血流动力学指标的影响研究[J].海峡药学,2012,24(10):243-244.
相似文献/References:
[1]罗春艳,刘洁.早发型重度子痫前期39例临床特点分析[J].中国计划生育和妇产科,2012,(01):0.
LUO Chun-yan,LIU Jie.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[2]刘颖,李增彦.早发型重度子痫前期临床分析[J].中国计划生育和妇产科,2014,(02):0.
LIU Ying,LI Zeng-yan,Tianjin Medical University,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.
[3]李卫文.早发型重度子痫前期患者的围产儿预后及影响因素分析[J].中国计划生育和妇产科,2015,(03):0.
LI Wei-wen,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(9):0.
[4]颜莉,龚莲,李爽.早发型重度子痫前期患者与慢性高血压并发早发型重度子痫前期患者的期待治疗时间与妊娠结局比较[J].中国计划生育和妇产科,2017,(3):61.
YAN Li,GONG Lian,LI Shuang.The comparison of expectant treatment time and pregnancy outcome between patients with early-onset severe preeclampsia and patients with chronic hypertension complicated with early-onset severe preeclampsia[J].Chinese Journal of Family Planning & Gynecotokology,2017,(9):61.
[5]黄婷.早发型和晚发型重度子痫前期临床指标的对比研究[J].中国计划生育和妇产科,2017,(8):27.
HUANG Ting.A comparative study of clinical indexes of early - onset and late - onset severe preeclampsia[J].Chinese Journal of Family Planning & Gynecotokology,2017,(9):27.
[6]赵丽娜,戴蕾,董武,等.趋化因子17与早发型重度子痫前期不良结局的相关性[J].中国计划生育和妇产科,2021,(2):47.
[J].Chinese Journal of Family Planning & Gynecotokology,2021,(9):47.